Towards A Systems Biology Understanding of Metabolic Disorder
Cosmo
©2012 MFMER | slide-1
Sodahead.com
©2012 MFMER | slide-2
©2012 MFMER | slide-3
seqanswers.com
Illumina
Life Tech: Ion Torrent
©2012 MFMER | slide-4
©2012 MFMER | slide-5
Transcriptomics – Expression Microarrays
©2012 MFMER | slide-6
©2012 MFMER | slide-7
Proteins !
©2012 MFMER | slide-8
Cell Signaling
©2012 MFMER | slide-9
©2012 MFMER | slide-10
Genome
Proteome
Transcriptome
©2012 MFMER | slide-11
A single cell ….
The Whole Body
©2012 MFMER | slide-12
©2012 MFMER | slide-13
Insulin Resistance (Periphery)
Impaired Insulin Secretion
X
X
©2012 MFMER | slide-14
What We Do
Before Exercise
After Exercise
Exercise
©2012 MFMER | slide-15
Gene Expression Microarrays (Transcriptome)
Mass Spectrometry (Proteome)
Genome
Sequencing
X
Homogenization
©2012 MFMER | slide-16
What can we learn from the genome?
©2012 MFMER | slide-17
Genome Wide Association Study (GWAS)
Empire State Building
Of Type 2 Diabetes
©2012 MFMER | slide-18
Blah
©2012 MFMER | slide-19
Blah
©2012 MFMER | slide-20
©2012 MFMER | slide-21
©2012 MFMER | slide-22
©2012 MFMER | slide-23
©2012 MFMER | slide-24
©2012 MFMER | slide-25
Transcriptomics – Expression Microarrays
©2012 MFMER | slide-26
Metabolic Phenotypes
Subject | | | | | | | | | | | | | | |
Sex | F | M | M | M | F | M | M | M | F | F | F | M | M | M |
Age (yrs) | 26 | 48 | 34 | 23 | 43 | 26 | 32 | 26 | 33 | 42 | 30 | 34 | 36 | 27 |
max HR pred | 194 | 172 | 186 | 197 | 177 | 194 | 188 | 194 | 187 | 178 | 190 | 186 | 184 | 193 |
Height(in) | 64.25 | 69.5 | 69.5 | 68.5 | 60.3 | 73 | 72 | 69.9 | 63.2 | 59.4 | 64.7 | 69.5 | 68.9 | 71.6 |
Weight (lbs) | 129.5 | 205.5 | 201 | 177 | 133 | 201 | 189 | 177.6 | 142 | 147.8 | 152 | 205 | 231 | 195.5 |
Wt (kg) | 58.86 | 93.41 | 91.36 | 80.45 | 60.45 | 91.36 | 85.91 | 80.73 | 64.55 | 67.04 | 69.1 | 92.99 | 104.9 | 88.8 |
BMI | 22.1 | 29.9 | 29.3 | 26.5 | 25.7 | 26.5 | 25.6 | 23.5 | 25 | 30 | 25.5 | 29.8 | 34.2 | 26.8 |
M (mg/kg/min) | 9.7 | 4.7 | 6.2 | 7.5 | 9 | 11.1 | 9.6 | 4.5 | 6.3 | 4.4 | 6.6 | 6.6 | 3.7 | 6.9 |
M (mg/min) | 571 | 439 | 566.5 | 603.4 | 544.1 | 1014 | 824.7 | 363.3 | 406.6 | 295 | 456.1 | 613.7 | 388.1 | 612.7 |
M (mg/kg/ffm) | 12.7 | 6.128 | 7.798 | 10.33 | 13.15 | 13.26 | 13.01 | 6.944 | 9.578 | 6.316 | 8.995 | 8.488 | 5.182 | 8.749 |
Body Fat % BAI | 23.6 | 23.3 | 20.5 | 27.4 | 28.6 | 15 | 26.2 | 29.4 | 34.2 | 30.5 | 26.1 | 22.2 | 28.5 | 21 |
Fat mass (lbs) | 30.6 | 47.9 | 41.2 | 48.5 | 36.5 | 29.7 | 49.5 | 47.9 | 48.6 | 45.2 | 39.5 | 45.5 | 65.8 | 41.1 |
Fat mass (kg) | 13.91 | 21.77 | 18.73 | 22.05 | 16.59 | 13.5 | 22.5 | 21.77 | 22.09 | 20.5 | 17.9 | 20.6 | 29.8 | 18.6 |
Lean Body Mass (lbs) | 98.9 | 157.6 | 159.8 | 128.5 | 91 | 168.3 | 139.5 | 115.1 | 93.4 | 102.9 | 111.8 | 159.5 | 165.2 | 154.4 |
Lean Body Mass (kg) | 44.95 | 71.64 | 72.64 | 58.41 | 41.36 | 76.5 | 63.41 | 52.32 | 42.45 | 46.7 | 50.7 | 72.3 | 74.9 | 70.03 |
BMR | 1365 | 2175 | 2205 | 1773 | 1256 | 2323 | 1925 | 1588 | 1289 | 1420 | 1540 | 2201 | 2280 | 2131 |
VO2 (l/m) | 1.81 | 2.8 | 3.27 | 2.5 | 1.54 | 4.46 | 2.86 | 2.79 | 1.82 | 1.49 | 1.72 | 4.05 | 3.48 | 2.86 |
VO2max (ml/kg/min) | 30.8 | 29.9 | 35.2 | 31.6 | 25.5 | 48.9 | 31.9 | 37.7 | 28.1 | 22.3 | 25.1 | 42 | 33.1 | 31.9 |
Heart Rate Max | 191 | 174 | 185 | 197 | 183 | 199 | 173 | 186 | 190 | 172 | 179 | 189 | 183 | 173 |
Watt max (W) | 165 | 200 | 200 | 175 | 125 | 260 | 200 | 175 | 125 | 100 | 125 | 230 | 175 | 200 |
Predicted70% max HR | 133.7 | 121.8 | 129.5 | 137.9 | 128.1 | 139.3 | 121.1 | 130.2 | 133 | 120.4 | 125.3 | 132.3 | 128.1 | 121.1 |
Predicted90% max HR | 171.9 | 156.6 | 166.5 | 177.3 | 164.7 | 179.1 | 155.7 | 167.4 | 171 | 154.8 | 161.1 | 170.1 | 164.7 | 155.7 |
Predicted70% max Watts | 115.5 | 140 | 140 | 122.5 | 87.5 | 182 | 140 | 122.5 | 87.5 | 70 | 87.5 | 161 | 122.5 | 140 |
90% max watts | 148.5 | 180 | 180 | 157.5 | 112.5 | 234 | 180 | 157.5 | 112.5 | 90 | 112.5 | 207 | 157.5 | 180 |
VO2 ml/kg/min | 30.8 | 29.9 | 35.2 | 31.6 | 25.5 | 48.9 | 31.9 | 37.7 | 28.1 | 22.3 | 25.1 | 42 | 33.1 | 31.9 |
VO2 (ml kg FFM) | 40.26 | 39.09 | 45.02 | 42.8 | 37.23 | 58.3 | 45.1 | 53.33 | 42.87 | 31.86 | 33.85 | 55.86 | 46.34 | 40.75 |
mean 70% max HR | 136.5 | 123.4 | 144.9 | 158.6 | 134 | 151.7 | 131.9 | 136.3 | 144.4 | 127.4 | 138.5 | 136.3 | 129.9 | 129.7 |
mean 90% max HR | 176.3 | 150.3 | 163.8 | 178.5 | 159.8 | 169.3 | 154.3 | 159.5 | 173.8 | 146 | 165.5 | 159.5 | 144.3 | 155.3 |
Chol | 202 | 201 | 165 | 183 | 145 | 154 | 145 | 165 | 183 | 190 | 157 | 169 | 213 | 206 |
TG | 56 | 227 | 114 | 78 | 55 | 44 | 94 | 119 | 98 | 93 | 152 | 57 | 204 | 258 |
HDL | 84 | 46 | 52 | 64 | 56 | 47 | 42 | 40 | 60 | 51 | 40 | 48 | 33 | 41 |
LDL | 109 | 117 | 94 | 106 | 80 | 100 | 87 | 105 | 107 | 124 | 92 | 112 | 146 | 113 |
VLDL | 9 | 38 | 19 | 13 | 9 | 7 | 16 | 20 | 16 | 16 | 25 | 10 | 34 | 43 |
HA1C | 5.1 | 5 | 5.3 | 5.1 | 5.7 | 5.5 | 5.8 | 5.5 | 5.7 | 5.4 | 4.9 | 5.5 | 5.8 | 5.7 |
Resting Heart Rate | 69 | 66 | 58 | 76 | 64 | 67 | 58 | 66 | 76 | 61 | 62 | 64 | 66 | 71 |
SBP | 113 | 143 | 122 | 130 | 108 | 131 | 94 | 112 | 113 | 104 | 106 | 141 | 126 | 144 |
DBP | 69 | 94 | 74 | 83 | 64 | 69 | 69 | 72 | 78 | 61 | 62 | 86 | 66 | 81 |
FPG mg/dl | 81.4 | 88.1 | 90 | 88.8 | 93.7 | 89.4 | 88.6 | 86.2 | 97.2 | 90.8 | 88.3 | 85.9 | 90.6 | 94.1 |
FPG mM | 4.522 | 4.894 | 5 | 4.933 | 5.206 | 4.967 | 4.922 | 4.789 | 5.4 | 5.044 | 4.906 | 4.772 | 5.033 | 5.228 |
FPI (uU/ml) | 2.9 | 10.67 | 6.35 | 5.15 | 6.7 | 4.52 | 3.74 | 2.79 | 3.66 | 7.75 | 16.67 | 8.41 | 13.53 | 1.89 |
FPI (pmol) | 17.4 | 64.02 | 38.1 | 30.9 | 40.2 | 27.12 | 22.44 | 16.74 | 21.96 | 46.5 | 100 | 50.46 | 81.18 | 11.34 |
clamp ins uU | 122 | 175 | 118 | 151 | 239 | 117 | 176 | 153 | 145 | 205 | 178 | 145 | 165 | 114 |
clamp pM | 732 | 1050 | 708 | 906 | 1434 | 702 | 1056 | 918 | 870 | 1230 | 1068 | 870 | 990 | 684 |
Glucose
Uptake
Rate
©2012 MFMER | slide-27
Distribution of Correlation Coefficients
©2012 MFMER | slide-28
Correlations With Glucose Uptake
Correlation | ID | Description |
0.86 | GOPC | Homo sapiens golgi associated PDZ and coiled-coil motif containing (GOPC) |
0.83 | ZBED3 | Homo sapiens zinc finger |
0.83 | MEA1 | Homo sapiens male-enhanced antigen 1 (MEA1) |
0.83 | BC014384 | Homo sapiens |
0.83 | GLUD1 | Homo sapiens glutamate dehydrogenase 1 (GLUD1) |
0.82 | PDE4A | Homo sapiens phosphodiesterase 4A |
0.81 | EIF4ENIF1 | Homo sapiens eukaryotic translation initiation factor 4E nuclear import factor 1 (EIF4ENIF1) |
0.8 | PPP2R3A | Homo sapiens protein phosphatase 2 (formerly 2A) |
0.79 | LOC401708 | PREDICTED: Homo sapiens similar to Glutamine synthetase (Glutamate--ammonia ligase) (GS) (LOC401708) |
0.79 | PPP2CB | Homo sapiens protein phosphatase 2 (formerly 2A) |
. | | |
. | | |
. | | |
-0.78 | ADRM1 | Homo sapiens adhesion regulating molecule 1 (ADRM1) |
-0.78 | NFKB1 | Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) (NFKB1) |
-0.78 | UBE2E3 | Homo sapiens ubiquitin-conjugating enzyme E2E 3 (UBC4/5 homolog |
-0.78 | PDXDC2 | Homo sapiens mRNA; cDNA DKFZp686B0962 (from clone DKFZp686B0962). [BX647358] |
-0.78 | RPLP0 | Homo sapiens ribosomal protein |
-0.79 | DYSF | Homo sapiens dysferlin |
-0.8 | EIF3S5 | Homo sapiens eukaryotic translation initiation factor 3 |
-0.8 | EEF1B2 | Homo sapiens eukaryotic translation elongation factor 1 beta 2 (EEF1B2) |
-0.8 | RPS3A | Homo sapiens ribosomal protein S3A (RPS3A) |
-0.8 | RPLP0 | Homo sapiens ribosomal protein |
-0.81 | A_24_P50489 | Unknown |
-0.83 | FBXO32 | Homo sapiens F-box protein 32 (FBXO32) |
-0.85 | LOC440350 | Homo sapiens similar to nuclear pore complex interacting protein (LOC440350) |
-0.85 | NFKB1 | Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) (NFKB1) |
-0.87 | FBXO9 | Homo sapiens F-box protein 9 (FBXO9) |
~40,000 OTHER Probes
©2012 MFMER | slide-29
©2012 MFMER | slide-30
ZBED3
ZBED3 is an INTERNAL
Receptor for WNT Signaling!
Axin
ZBED3
Axin
ZBED3
©2012 MFMER | slide-31
ZBED3
ZBED3 Overexpression ENHANCES
WNT Signaling
ZBED3 KnockDown BLUNTS
WNT Signaling
©2012 MFMER | slide-32
ZBED3 Expression Correlates With Glucose Uptake !!!
©2012 MFMER | slide-33
PP2A = Protein Phosphatase 2
©2012 MFMER | slide-34
Top Correlate : GOPC
©2012 MFMER | slide-35
©2012 MFMER | slide-36
©2012 MFMER | slide-37
GOPC
Frizzled
Golgi
8 Hours
20 Hours
©2012 MFMER | slide-38
©2012 MFMER | slide-39
What About the Negative Correlates ?
WNT Signaling
Glucose Transportor trafficking
Muscle Atrophy / Wasting
©2012 MFMER | slide-40
©2012 MFMER | slide-41
©2012 MFMER | slide-42
ADRM1 = RPN13 -> Activates Proteosome!
©2012 MFMER | slide-43
©2012 MFMER | slide-44
©2012 MFMER | slide-45
Does this correlation make sense?
When starving, peripheral tissues should :
How can atrophy directly disable glucose uptake ?
©2012 MFMER | slide-46
©2012 MFMER | slide-47
Can Atrogin switch off glucose uptake ?
GOPC
Frizzled
Golgi
Cell Membrane
Frizzled
S/T – X - V
Atrogin
BK Channels
S/T – X - V
©2012 MFMER | slide-48
Hypothesis : �GOPC is on-switch / Atrogin is off-switch
GOPC
Frizzled
Golgi
Cell Membrane
Frizzled
S/T – X - V
Atrogin
S/T – X - V
X
X
©2012 MFMER | slide-49
What about FBXO9 ?
FBXO9 turns on adipogenesis !
Kills B-catenin
©2012 MFMER | slide-50
What about FBXO9 ?
FBXO9
?
Wnt signaling Anti - adipogenesis
FBXO9 Pro - adipogenesis !
©2012 MFMER | slide-51
©2012 MFMER | slide-52
DYSF = Dysferlin : Muscular Dystrophy
©2012 MFMER | slide-53
©2012 MFMER | slide-54
What About the Negative Correlates ?
WNT Signaling
Glucose Transportor trafficking
Muscle Atrophy / Wasting
Causes :
Disuse ?
Starvation / Fasting ?
Inflammation ?
Inhibition ?
©2012 MFMER | slide-55
Correlations with Exercise Fold Change
Correlation | ID | Description |
0.86 | KCNMB2 | potassium large conductance calcium-activated channel |
0.86 | ACP5 | acid phosphatase 5 |
0.85 | LIN28B | lin-28 homolog B (C. elegans) (LIN28B) |
0.84 | A_24_P941450 | Unknown |
0.84 | HAO2 | hydroxyacid oxidase 2 (long chain) (HAO2) |
0.83 | AL157439 | mRNA; cDNA DKFZp434A225 (from clone DKFZp434A225). [AL157439] |
0.81 | PRKAG2 | cDNA FLJ90194 fis |
0.81 | GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) (GPX4) |
0.80 | AF349445 | maxi-K channel HSLO mRNA |
0.80 | TJAP1 | tight junction associated protein 1 (peripheral) (TJAP1) |
0.79 | TRIM43 | tripartite motif-containing 43 (TRIM43) |
0.79 | AF116673 | PRO1925 mRNA |
0.79 | DGKZ | diacylglycerol kinase |
0.79 | KIAA1772 | KIAA1772 (KIAA1772) |
0.79 | SART3 | squamous cell carcinoma antigen recognized by T cells 3 (SART3) |
0.78 | CBFA2T2 | core-binding factor |
0.78 | A_23_P123234 | Unknown |
0.78 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2 |
0.78 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2 |
©2012 MFMER | slide-56
©2012 MFMER | slide-57
©2012 MFMER | slide-58
Figure 1. A transgenic TRAP over expressing mouse subline displays hyperplastic obesity.
Lång P, van Harmelen V, Rydén M, Kaaman M, et al. (2008) Monomeric Tartrate Resistant Acid Phosphatase Induces Insulin Sensitive Obesity. PLoS ONE 3(3): e1713. doi:10.1371/journal.pone.0001713
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0001713
©2012 MFMER | slide-59
©2012 MFMER | slide-60
©2012 MFMER | slide-61
NFKB1 -> Atrophy pathway !
©2012 MFMER | slide-62
©2012 MFMER | slide-63
Macrophage
avb3
OPN
M1 Polarization
Inflammatory
Cytokine Secretion
©2012 MFMER | slide-64
Glucose Disposal
Rate !
©2012 MFMER | slide-65
Figure 1. A transgenic TRAP over expressing mouse subline displays hyperplastic obesity.
OPN
OPN
ACP5/TRAP
TRAP dephosphorylates
Osteopontin
Prevents binding with avb-3 integrin receptors
©2012 MFMER | slide-66
Macrophage
avb3
OPN
X
Inflammatory
Cytokines
X
OPN
OPN
ACP5/TRAP
©2012 MFMER | slide-67
©2012 MFMER | slide-68
The Big Picture
FBXO9
FBXO32/Atrogin
(Maybe)
X
©2012 MFMER | slide-69
What about correlation with other measurements ?
Subject | | | | | | | | | | | | | | |
Sex | F | M | M | M | F | M | M | M | F | F | F | M | M | M |
Age (yrs) | 26 | 48 | 34 | 23 | 43 | 26 | 32 | 26 | 33 | 42 | 30 | 34 | 36 | 27 |
max HR pred | 194 | 172 | 186 | 197 | 177 | 194 | 188 | 194 | 187 | 178 | 190 | 186 | 184 | 193 |
Height(in) | 64.25 | 69.5 | 69.5 | 68.5 | 60.3 | 73 | 72 | 69.9 | 63.2 | 59.4 | 64.7 | 69.5 | 68.9 | 71.6 |
Weight (lbs) | 129.5 | 205.5 | 201 | 177 | 133 | 201 | 189 | 177.6 | 142 | 147.8 | 152 | 205 | 231 | 195.5 |
Wt (kg) | 58.86 | 93.41 | 91.36 | 80.45 | 60.45 | 91.36 | 85.91 | 80.73 | 64.55 | 67.04 | 69.1 | 92.99 | 104.9 | 88.8 |
BMI | 22.1 | 29.9 | 29.3 | 26.5 | 25.7 | 26.5 | 25.6 | 23.5 | 25 | 30 | 25.5 | 29.8 | 34.2 | 26.8 |
M (mg/kg/min) | 9.7 | 4.7 | 6.2 | 7.5 | 9 | 11.1 | 9.6 | 4.5 | 6.3 | 4.4 | 6.6 | 6.6 | 3.7 | 6.9 |
M (mg/min) | 571 | 439 | 566.5 | 603.4 | 544.1 | 1014 | 824.7 | 363.3 | 406.6 | 295 | 456.1 | 613.7 | 388.1 | 612.7 |
M (mg/kg/ffm) | 12.7 | 6.128 | 7.798 | 10.33 | 13.15 | 13.26 | 13.01 | 6.944 | 9.578 | 6.316 | 8.995 | 8.488 | 5.182 | 8.749 |
Body Fat % BAI | 23.6 | 23.3 | 20.5 | 27.4 | 28.6 | 15 | 26.2 | 29.4 | 34.2 | 30.5 | 26.1 | 22.2 | 28.5 | 21 |
Fat mass (lbs) | 30.6 | 47.9 | 41.2 | 48.5 | 36.5 | 29.7 | 49.5 | 47.9 | 48.6 | 45.2 | 39.5 | 45.5 | 65.8 | 41.1 |
Fat mass (kg) | 13.91 | 21.77 | 18.73 | 22.05 | 16.59 | 13.5 | 22.5 | 21.77 | 22.09 | 20.5 | 17.9 | 20.6 | 29.8 | 18.6 |
Lean Body Mass (lbs) | 98.9 | 157.6 | 159.8 | 128.5 | 91 | 168.3 | 139.5 | 115.1 | 93.4 | 102.9 | 111.8 | 159.5 | 165.2 | 154.4 |
Lean Body Mass (kg) | 44.95 | 71.64 | 72.64 | 58.41 | 41.36 | 76.5 | 63.41 | 52.32 | 42.45 | 46.7 | 50.7 | 72.3 | 74.9 | 70.03 |
BMR | 1365 | 2175 | 2205 | 1773 | 1256 | 2323 | 1925 | 1588 | 1289 | 1420 | 1540 | 2201 | 2280 | 2131 |
VO2 (l/m) | 1.81 | 2.8 | 3.27 | 2.5 | 1.54 | 4.46 | 2.86 | 2.79 | 1.82 | 1.49 | 1.72 | 4.05 | 3.48 | 2.86 |
VO2max (ml/kg/min) | 30.8 | 29.9 | 35.2 | 31.6 | 25.5 | 48.9 | 31.9 | 37.7 | 28.1 | 22.3 | 25.1 | 42 | 33.1 | 31.9 |
Heart Rate Max | 191 | 174 | 185 | 197 | 183 | 199 | 173 | 186 | 190 | 172 | 179 | 189 | 183 | 173 |
Watt max (W) | 165 | 200 | 200 | 175 | 125 | 260 | 200 | 175 | 125 | 100 | 125 | 230 | 175 | 200 |
Predicted70% max HR | 133.7 | 121.8 | 129.5 | 137.9 | 128.1 | 139.3 | 121.1 | 130.2 | 133 | 120.4 | 125.3 | 132.3 | 128.1 | 121.1 |
Predicted90% max HR | 171.9 | 156.6 | 166.5 | 177.3 | 164.7 | 179.1 | 155.7 | 167.4 | 171 | 154.8 | 161.1 | 170.1 | 164.7 | 155.7 |
Predicted70% max Watts | 115.5 | 140 | 140 | 122.5 | 87.5 | 182 | 140 | 122.5 | 87.5 | 70 | 87.5 | 161 | 122.5 | 140 |
90% max watts | 148.5 | 180 | 180 | 157.5 | 112.5 | 234 | 180 | 157.5 | 112.5 | 90 | 112.5 | 207 | 157.5 | 180 |
VO2 ml/kg/min | 30.8 | 29.9 | 35.2 | 31.6 | 25.5 | 48.9 | 31.9 | 37.7 | 28.1 | 22.3 | 25.1 | 42 | 33.1 | 31.9 |
VO2 (ml kg FFM) | 40.26 | 39.09 | 45.02 | 42.8 | 37.23 | 58.3 | 45.1 | 53.33 | 42.87 | 31.86 | 33.85 | 55.86 | 46.34 | 40.75 |
mean 70% max HR | 136.5 | 123.4 | 144.9 | 158.6 | 134 | 151.7 | 131.9 | 136.3 | 144.4 | 127.4 | 138.5 | 136.3 | 129.9 | 129.7 |
mean 90% max HR | 176.3 | 150.3 | 163.8 | 178.5 | 159.8 | 169.3 | 154.3 | 159.5 | 173.8 | 146 | 165.5 | 159.5 | 144.3 | 155.3 |
Chol | 202 | 201 | 165 | 183 | 145 | 154 | 145 | 165 | 183 | 190 | 157 | 169 | 213 | 206 |
TG | 56 | 227 | 114 | 78 | 55 | 44 | 94 | 119 | 98 | 93 | 152 | 57 | 204 | 258 |
HDL | 84 | 46 | 52 | 64 | 56 | 47 | 42 | 40 | 60 | 51 | 40 | 48 | 33 | 41 |
LDL | 109 | 117 | 94 | 106 | 80 | 100 | 87 | 105 | 107 | 124 | 92 | 112 | 146 | 113 |
VLDL | 9 | 38 | 19 | 13 | 9 | 7 | 16 | 20 | 16 | 16 | 25 | 10 | 34 | 43 |
HA1C | 5.1 | 5 | 5.3 | 5.1 | 5.7 | 5.5 | 5.8 | 5.5 | 5.7 | 5.4 | 4.9 | 5.5 | 5.8 | 5.7 |
Resting Heart Rate | 69 | 66 | 58 | 76 | 64 | 67 | 58 | 66 | 76 | 61 | 62 | 64 | 66 | 71 |
SBP | 113 | 143 | 122 | 130 | 108 | 131 | 94 | 112 | 113 | 104 | 106 | 141 | 126 | 144 |
DBP | 69 | 94 | 74 | 83 | 64 | 69 | 69 | 72 | 78 | 61 | 62 | 86 | 66 | 81 |
FPG mg/dl | 81.4 | 88.1 | 90 | 88.8 | 93.7 | 89.4 | 88.6 | 86.2 | 97.2 | 90.8 | 88.3 | 85.9 | 90.6 | 94.1 |
FPG mM | 4.522 | 4.894 | 5 | 4.933 | 5.206 | 4.967 | 4.922 | 4.789 | 5.4 | 5.044 | 4.906 | 4.772 | 5.033 | 5.228 |
FPI (uU/ml) | 2.9 | 10.67 | 6.35 | 5.15 | 6.7 | 4.52 | 3.74 | 2.79 | 3.66 | 7.75 | 16.67 | 8.41 | 13.53 | 1.89 |
FPI (pmol) | 17.4 | 64.02 | 38.1 | 30.9 | 40.2 | 27.12 | 22.44 | 16.74 | 21.96 | 46.5 | 100 | 50.46 | 81.18 | 11.34 |
clamp ins uU | 122 | 175 | 118 | 151 | 239 | 117 | 176 | 153 | 145 | 205 | 178 | 145 | 165 | 114 |
clamp pM | 732 | 1050 | 708 | 906 | 1434 | 702 | 1056 | 918 | 870 | 1230 | 1068 | 870 | 990 | 684 |
Body Mass
Index
©2012 MFMER | slide-70
That’s 2 GWAS
Connections !
©2012 MFMER | slide-71
�Exercise:� Lowers LRP1B in thin people� Raises LRP1B in fat people ……
©2012 MFMER | slide-72
Transcriptomics – Expression Microarrays
©2012 MFMER | slide-73
©2012 MFMER | slide-74
Cell Signaling
©2012 MFMER | slide-75
Proteomics – Mass Spectrometry
©2012 MFMER | slide-76
©2012 MFMER | slide-77
Molecular Modeling Reveals Acetylation of Adenine Nucleotide Translocase (ANT)1 Regulates Affinity for ADP
Clinton Mielke, Banu Ozkan, Andrew Bordner, Jerez Te, Wayne T. Willis, Lawrence J. Mandarino
©2012 MFMER | slide-78
©2012 MFMER | slide-79
Acetylation at K23 Correlates With Insulin Resistance
©2012 MFMER | slide-80
©2012 MFMER | slide-81
m-state
c-state
©2012 MFMER | slide-82
ANT1 is acetylated at lysines 10, 23, and 92 in vivo in human muscle.
©2012 MFMER | slide-83
Making the Acetyl-Lysine
©2012 MFMER | slide-84
Electrostatics
©2012 MFMER | slide-85
ANT1 Gating Mechanism
©2012 MFMER | slide-86
Simulation Movie
©2012 MFMER | slide-87
Simulation with ADP
©2012 MFMER | slide-88
Docking Experiments
©2012 MFMER | slide-89
Yeast Mutagenesis Study
Site-directed mutagenesis of the yeast mitochondrial ADP/ATP translocator. Six arginines and one lysine are essential.
J Mol Biol. 1993 Apr 20;230(4):1159-70.
©2012 MFMER | slide-90
Another Unfinished Story
©2012 MFMER | slide-91
©2012 MFMER | slide-92
IRS1 Phosphorylation in Insulin Resistance
IRS1 : DGYMPMSPGVAPVPSGRKGSGDYMPMSPKSV
Y612 + S616
Y632 + S636
©2012 MFMER | slide-93
COSMIC Database
ALL Mutations in COSMIC
7th!
H1047R
©2012 MFMER | slide-94
The last mutation
Molecular Cell : 2011
IRS1 : DGYMPMSPGVAPVPSGRKGSGDYMPMSPKSV
Mutation 1047!
*
©2012 MFMER | slide-95
Mutations (Genome) → “Source Code”
Modifications (Proteome) → “RAM”
Both can switch on/off proteins
How can we find all of these
molecular switches?
©2012 MFMER | slide-96
AMASS (amass-db.org)
©2012 MFMER | slide-97
©2012 MFMER | slide-98
©2012 MFMER | slide-99
~330 lbs
©2012 MFMER | slide-100
©2012 MFMER | slide-101
©2012 MFMER | slide-102
©2012 MFMER | slide-103
If You’re Not Excited, You Should Be!
©2012 MFMER | slide-104